GP
ABMD

Girard Partners’s Abiomed Inc ABMD Stock Holding History

Girard Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-800
Closed -$264K – 232
2022
Q1 		$264K Hold
800
– – 0.03% 203
2021
Q4 		$287K Hold
800
– – 0.03% 202
2021
Q3 		$260K Buy
+800
New +$271K 0.03% 202
2019
Q1 		– Sell
-676
Closed -$219K – 247
2018
Q4 		$219K Buy
676
+521
+336% +$181K 0.05% 224
2018
Q3 		$69K Sell
155
-1,112
-88% -$438K 0.01% 400
2018
Q2 		$518K Buy
+1,267
New +$459K 0.1% 164

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Girard Partners's ABMD Position: Q2 2022 in Review

Girard Partners sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 800 shares — an estimated $264K sold.

Girard Partners first reported a position in ABMD in Q2 2018 and held it in 6 quarters. The position peaked at $518K in Q2 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Girard Partners reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Girard Partners sold 800 Abiomed Inc shares in Q2 2022, an estimated $264K.
  • Girard Partners first reported a position in Abiomed Inc in Q2 2018 and held it in 6 quarters.
  • Girard Partners's Abiomed Inc position peaked at $518K in Q2 2018.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Girard Partners's 13F filing for Q2 2022, filed 26 Jul 2022.